Annual ROE
199.53%
+725.67%+137.92%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual return on equity is currently 199.53%, with the most recent change of +725.67% (+137.92%) on 31 December 2023. During the last 3 years, it has risen by +269.45% (+385.37%). ALNY annual ROE is now at all-time high.ALNY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
323.66%
+275.74%+575.42%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly return on equity is currently 323.66%, with the most recent change of +275.74% (+575.42%) on 30 September 2024. Over the past year, it has increased by +117.96% (+57.35%). ALNY quarterly ROE is now -50.68% below its all-time high of 656.18%, reached on 30 June 2004.ALNY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +137.9% | +57.4% |
| 3 y3 years | +385.4% | +468.3% |
| 5 y5 years | +502.0% | +706.1% |
ALNY ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +137.9% | -32.0% | +105.6% |
| 5 y | 5 years | at high | +137.9% | -32.0% | +105.6% |
| alltime | all time | at high | +137.9% | -50.7% | +105.6% |
Alnylam Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 323.66%(+575.4%) |
| June 2024 | - | 47.92%(-63.4%) |
| Mar 2024 | - | 131.01%(-21.6%) |
| Dec 2023 | 199.53%(-137.9%) | 167.09%(-18.8%) |
| Sept 2023 | - | 205.70%(-56.8%) |
| June 2023 | - | 476.27%(-108.2%) |
| Mar 2023 | - | -5780.99%(+860.3%) |
| Dec 2022 | -526.14%(+394.9%) | -601.97%(+88.8%) |
| Sept 2022 | - | -318.86%(+80.4%) |
| June 2022 | - | -176.73%(+39.5%) |
| Mar 2022 | - | -126.66%(+23.0%) |
| Dec 2021 | -106.31%(+52.0%) | -103.00%(+17.2%) |
| Sept 2021 | - | -87.89%(+7.3%) |
| June 2021 | - | -81.94%(+10.5%) |
| Mar 2021 | - | -74.18%(+11.0%) |
| Dec 2020 | -69.92%(+8.1%) | -66.85%(+5.2%) |
| Sept 2020 | - | -63.54%(+13.4%) |
| June 2020 | - | -56.02%(-2.7%) |
| Mar 2020 | - | -57.56%(-0.6%) |
| Dec 2019 | -64.66%(+30.3%) | -57.90%(+8.4%) |
| Sept 2019 | - | -53.40%(-4.1%) |
| June 2019 | - | -55.69%(+7.0%) |
| Mar 2019 | - | -52.07%(+8.3%) |
| Dec 2018 | -49.63%(+35.8%) | -48.06%(+6.6%) |
| Sept 2018 | - | -45.08%(+15.9%) |
| June 2018 | - | -38.91%(-3.1%) |
| Mar 2018 | - | -40.16%(-6.7%) |
| Dec 2017 | -36.54%(-2.7%) | -43.06%(-7.7%) |
| Sept 2017 | - | -46.64%(+5.1%) |
| June 2017 | - | -44.38%(+8.2%) |
| Mar 2017 | - | -41.00%(+9.7%) |
| Dec 2016 | -37.54%(+42.4%) | -37.37%(+13.5%) |
| Sept 2016 | - | -32.93%(+14.7%) |
| June 2016 | - | -28.70%(+12.0%) |
| Mar 2016 | - | -25.62%(+13.6%) |
| Dec 2015 | -26.36%(-55.9%) | -22.56%(+24.0%) |
| Sept 2015 | - | -18.19%(+10.1%) |
| June 2015 | - | -16.52%(+7.9%) |
| Mar 2015 | - | -15.31%(-65.9%) |
| Dec 2014 | -59.74% | -44.96%(-18.4%) |
| Sept 2014 | - | -55.10%(-14.4%) |
| June 2014 | - | -64.37%(-16.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -77.28%(+129.0%) |
| Dec 2013 | -44.13%(-47.5%) | -33.75%(-30.3%) |
| Sept 2013 | - | -48.45%(-0.4%) |
| June 2013 | - | -48.64%(-5.4%) |
| Mar 2013 | - | -51.40%(-21.0%) |
| Dec 2012 | -84.12%(+101.5%) | -65.05%(+81.0%) |
| Sept 2012 | - | -35.94%(+6.5%) |
| June 2012 | - | -33.76%(-7.1%) |
| Mar 2012 | - | -36.35%(-13.5%) |
| Dec 2011 | -41.74%(+61.2%) | -42.00%(+21.8%) |
| Sept 2011 | - | -34.49%(+13.3%) |
| June 2011 | - | -30.44%(+2.8%) |
| Mar 2011 | - | -29.61%(+13.5%) |
| Dec 2010 | -25.89%(+3.4%) | -26.08%(+0.9%) |
| Sept 2010 | - | -25.86%(+3.8%) |
| June 2010 | - | -24.92%(-12.3%) |
| Mar 2010 | - | -28.43%(+13.0%) |
| Dec 2009 | -25.04%(+91.4%) | -25.17%(-0.6%) |
| Sept 2009 | - | -25.31%(+16.9%) |
| June 2009 | - | -21.66%(+32.6%) |
| Mar 2009 | - | -16.33%(+25.4%) |
| Dec 2008 | -13.08%(-69.4%) | -13.02%(+71.1%) |
| Sept 2008 | - | -7.61%(-77.3%) |
| June 2008 | - | -33.46%(-0.8%) |
| Mar 2008 | - | -33.74%(-24.0%) |
| Dec 2007 | -42.70%(+62.2%) | -44.39%(-19.3%) |
| Sept 2007 | - | -55.04%(+72.3%) |
| June 2007 | - | -31.94%(-2.4%) |
| Mar 2007 | - | -32.73%(+12.7%) |
| Dec 2006 | -26.32%(-66.9%) | -29.05%(-40.3%) |
| Sept 2006 | - | -48.68%(-24.2%) |
| June 2006 | - | -64.19%(-22.7%) |
| Mar 2006 | - | -83.05%(-22.5%) |
| Dec 2005 | -79.53%(-76.3%) | -107.17%(+15.2%) |
| Sept 2005 | - | -93.02%(+31.5%) |
| June 2005 | - | -70.76%(-21.4%) |
| Mar 2005 | - | -90.05%(-58.1%) |
| Dec 2004 | -336.03%(-458.5%) | -214.80%(-51.7%) |
| Sept 2004 | - | -444.77%(-167.8%) |
| June 2004 | - | 656.18%(+635.6%) |
| Mar 2004 | - | 89.20%(+33.0%) |
| Dec 2003 | 93.73%(+5.3%) | 67.06% |
| Dec 2002 | 89.02% | - |
FAQ
- What is Alnylam Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual ROE year-on-year change?
- What is Alnylam Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly ROE year-on-year change?
What is Alnylam Pharmaceuticals annual return on equity?
The current annual ROE of ALNY is 199.53%
What is the all time high annual ROE for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual return on equity is 199.53%
What is Alnylam Pharmaceuticals annual ROE year-on-year change?
Over the past year, ALNY annual return on equity has changed by +725.67% (+137.92%)
What is Alnylam Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ALNY is 323.66%
What is the all time high quarterly ROE for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly return on equity is 656.18%
What is Alnylam Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ALNY quarterly return on equity has changed by +117.96% (+57.35%)